Tag Archives: wearables

Vijay Parmar

Microbattery Advancements Will Unlock a New Wave of MedTech Innovation

By Vijay Parmar
Vijay Parmar

Microbatteries are on the cusp of a new era as solid-state lithium technology arrives to pack more energy into smaller form factors. These batteries will enable the products they power to be offered in smaller sizes and more comfortable shapes, with enormous implications for future medtech product designs and capabilities, from the convergence of hearables and OTC hearing aids to wearable devices that are used for remote health monitoring and fitness tracking.

Continue reading

John Mastrototaro

Next Steps in Wearables

By MedTech Intelligence Staff
John Mastrototaro

John Mastrototaro, Ph.D., biomedical engineer and CEO of Movano discusses strategies to improve data accuracy, the convergence of consumer wearables and medical remote monitoring devices and what healthcare providers are seeking in remote data delivery.

Continue reading

Healthcare Technology

Critical Issues in Remote Monitoring: Data Capture and Quality

By Jennifer Kent, Ph.D.
Healthcare Technology

As more healthcare activities take place from home, passive continuous monitoring solutions and new technology such as artificial intelligence will be critical to communications between providers and patients. In addition, new solutions that offer overnight monitoring will play a crucial role in helping to fill the gaps, particularly in assessing patient deterioration or changes in health conditions. The pandemic has forever changed the trajectory of healthcare and specifically virtual care.

Continue reading

Artificial intelligence, medical devices

The Regulatory Aspects of AI/ML-based SaMD

By Zuhal Reed
Artificial intelligence, medical devices

Modern technology has given rise to new legal questions. How does FDA regulate machine-learning computers that are changing so rapidly – given that the approved product may be drastically different than the product that ends up on the market? These questions arise from a lack of understanding of the complex nature of AI/ML-based SaMD, the opaqueness of the regulatory framework, and a dearth of relevant case law.

Continue reading